• Издательство
  • Издательство
  • Издания
  • Журнал Сердечная Недостаточность
  • 2014
  • Регистр госпитализированных пациентов с декомпенсацией кровообращения (регистр Павловской больницы). Сообщение 2. Клиническое значение и прогностическая роль некоторых параметров, определяемых при физикальном и инструментальном обследовании пациентов с де

Журнал Сердечная Недостаточность 2014 год Регистр госпитализированных пациентов с декомпенсацией кровообращения (регистр Павловской больницы). Сообщение 2. Клиническое значение и прогностическая роль некоторых параметров, определяемых при физикальном и инструментальном обследовании пациентов с де


Для доступа к данному материалу пожалуйста авторизуйтесь или зарегистрируйтесь

Зарегистрируйтесь Авторизуйтесь
2014/№2

Регистр госпитализированных пациентов с декомпенсацией кровообращения (регистр Павловской больницы). Сообщение 2. Клиническое значение и прогностическая роль некоторых параметров, определяемых при физикальном и инструментальном обследовании пациентов с декомпенсацией кровообращения

Арутюнов А. Г., Рылова А. К., Арутюнов Г. П.
ГБОУ ВПО «РНИМУ им. Н. И. Пирогова» МЗ РФ, 117997, Москва, ул. Островитянова, д. 1

Ключевые слова: декомпенсация кровообращения, регистр, эпидемиология

DOI: 10.18087 / rhfj.2014.2.1934

В настоящем сообщении продолжается обсуждение основных результатов регистра Павловской больницы.
  1. Dickstein K, Cohen-Solal A, Filippatos G et al; ESC Committee for Practice Guidelines (CPG) / ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10 (10):933–989.
  2. Lainscak M, Blue L, Clark AL et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2011;13 (2):115–126.
  3. Cleland JG, Swedberg K, Follath F et al. The EuroHeart Failure survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003 Mar;24 (5):442–63.
  4. Androne AS, Katz SD, Lung L et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107 (2):226–229.
  5. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003 Jun 1;114 (8):625–30.
  6. Webel AR, Frazier SK, Moser DK, Lennie TA. Daily variability in dyspnea, edema and body weight in heart failure patients. Eur J Cardiovasc Nurs. 2007 Mar;6 (1):60–5.
  7. Lewin J, Ledwidge M, O'Loughlin C et al. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail. 2005 Oct;7 (6):953–7.
  8. Hunt SA, Abraham WT, Chin MH et al. ACC / AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112 (12):e154–235.
  9. Adams KF, Lindenfeld J, Arnold JMO et al. Executive summary: Heart Failure Society of America 2006 comprehensive heart failure practice guidelines. J Card Fail. 2006 Feb;12 (1):10–38.
  10. Konstam MA, Gheorghiade M, Burnett JC Jr et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297 (12):1319–31.
  11. Blair JE, Khan S, Konstam MA et al. Weight changes after hospita­lization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009 Jul;30 (13):1666–73.
  12. Mehta RH, Rogers JG, Hasselblad V et al. Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE). Am J Cardiol. 2009 Jan 1;103 (1):76–81.
  13. Gheorghiade M, Zannad F, Sopko G et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112 (25):3958–3968.
  14. Allen LA, Metra M, Milo-Cotter O et al. Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF). J Card Fail. 2008 Nov;14 (9):777–84.
  15. Blair JE, Khan S, Konstam MA et al EVEREST Investigators. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009 Jul;30 (13):1666–73.
  16. Domanski M, Norman J, Pitt B et al. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 2003 Aug 20;42 (4):705–8.
  17. Hasselblad V, Gattis Stough W, Shah MR et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007 Oct;9 (10):1064–9.
  18. Chaudhry SI, Wang Y, Concato J et al. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116 (14):1549–1554
  19. Lewin J, Ledwidge M, O'Loughlin C et al. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail. 2005 Oct;7 (6):953–7.
  20. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001 Aug 23;345 (8):574–81.
  21. Adamson PB, Magalski A, Braunschweig F et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41 (4):565–571.
  22. Goldberg LR, Piette JD, Walsh MN et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003 Oct;146 (4):705–12.
  23. Lyngå P, Persson H, Hägg-Martinell A et al. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. Eur J Heart Fail. 2012 Apr;14 (4):438–44.
  24. Levy D, Larson MG, Vasan RS et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275 (20):1557–1562.
  25. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996 Apr;27 (5):1214–8.
  26. Beckett NS, Peters R, Fletchers AE et al. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med. 2008;358 (18):1887–1898.
  27. Bhatia RS, Tu JV, Lee DS et al. Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study. N Engl J Med. 2006;355 (3):260–269.
  28. Fonarow GC, Adams KF Jr, Abraham WT et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293 (5):572–580.
  29. Gheorghiade M, Abraham WT, Albert NM et al; for the OPTIMIZE-HF Investigators Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006 Nov 8;296 (18):2217–26.
  30. Huynh BC, Rovner A, Rich MW. Long-term Survival in Elderly Patients Hospitalized for Heart Failure 14‑Year Follow-up From a Prospective Randomized Trial. Arch Intern Med. 2006;166 (17):1892–1898.
  31. Lee DS, Austin PC, Rouleau JL et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003 Nov 19;290 (19):2581–7.
  32. Adams KF, Fonarow GC, Emerman CL et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149 (2):209–216.
  33. McMurray JJ, Carson PE, Komajda M et al. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008;10 (2):149–156.
  34. Vidán MT, Bueno H, Wang Y et al. The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail. 2010 Feb;12 (2):148–55.
  35. Huynh BC, Rovner A, Rich MW. Identification of older patients with heart failure who may be candidates for hospice care: deve­lopment of a simple four-item risk score. J Am Geriatr Soc. 2008 Jun;56 (6):1111–5.
  36. Zannad F, Mebazaa A, Juillière Y et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail. 2006 Nov;8 (7):697–705.
  37. Grigorian-Shamagian L, Gonzalez-JuAnatey JR, Vazquez R et al. Association of blood pressure and its evolving changes with the survival of patients with heart failure. J Card Fail. 2008;14 (7):561–568.
  38. Lee TT, Chen J, Cohen DJ, Tsao L. The association between blood pressure and mortality in patients with heart failure. Am Heart J. 2006;151 (1):76–83.
  39. Abraham WT, Fonarow GC, Albert NM et al; on behalf of the OPTIMIZE-HF Investigators Coordinators. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008 Jul 29;52 (5):347–56.
  40. Hillege HL, Girbes AR, De Cam PJ et al. Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation. 2000;102 (2):203–210.
  41. Hillege HL, Nitsch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113 (5):671–678.
  42. McAlister FA, Ezekowitz J, Toneli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109 (8):1004–1009.
  43. Damman K, Jaarsma T, Voors AA et al. COACH investigators. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail. 2009 Sep;11 (9):847–54.
  44. Smith GL, Lichtman JH, Bracken MB et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47 (10):1987–1996.
  45. Damman K, Navis G, Voors AA et al. Worsening renal function and prognosis in heart failure:systematic review and meta-analysis. J Card Fail. 2007;13 (8):599–608.
  46. Butler J, Chirovsky D, Phatak H et al. Renal function, health outcomes, and resource utilization in acute heart failure: a systematic review. Circ Heart Fail. 2010 Nov;3 (6):726–45.
  47. Filippatos G, Rossi J, Lloyd-Jones DM et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail. 2007 Jun;13 (5):360–4.
  48. Klein L, Massie BM, Leimberger JD et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008;1 (1):25–33.
  49. Metra M, Nodari S, Parrinello G et al. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008 Feb;10 (2):188–95.
  50. Forman DE, Butler J, Wang Y et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43 (1):61–67.
  51. Testani JM, Coca SG, McCauley BD et al. Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail. 2011 Aug;13 (8):877–84.
  52. Voors AA, Davison BA, Felker GM et al. Pre-RELAX-AHF study group. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail. 2011 Sep;13 (9):961–7.
  53. Ruggenenti P, Remuzzi G. Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney. Eur Heart J. 2011;32 (20):2476–2478.
  54. Metra M, Davison B, Bettari L et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure?: the role of congestion and its interaction with renal function. Circ Heart Fail. 2012 Jan;5 (1):54–62.
  55. Testani JM, Chen J, McCauley BD et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010 Jul 20;122 (3):265–72.
  56. Felker GM, Lee KL, Bull DA et al. NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 3;364 (9):797–805.
  57. Metra M, O'Connor CM, Davison BA et al. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J. 2011 Jun;32 (12):1519–34.
  58. Blair JE, Pang PS, Schrier RW et al. Changes in renal function du­ring hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011;32 (20):2563–2572.
  59. Metra M, Davison B, Bettari L et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012 Jan;5 (1):54–62.
  60. Schrier RW. Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail. 2008 May;1 (1):2–5.
  61. Beier K, Eppanapally S, Bazick HS et al. Elevation of BUN is predictive of long-term mortality in critically ill patients independent of 'normal' creatinine. Crit Care Med. 2011 Feb;39 (2):305–13.
Арутюнов А. Г., Рылова А. К., Арутюнов Г. П. Регистр госпитализированных пациентов с декомпенсацией кровообращения (регистр Павловской больницы). Сообщение 2. Клиническое значение и прогностическая роль некоторых параметров, определяемых при физикальном и инструментальном обследовании пациентов с декомпенсацией кровообращения. Журнал Сердечная Недостаточность. 2014;83 (2):67–75

Для доступа к данному материалу пожалуйста авторизуйтесь или зарегистрируйтесь

Зарегистрируйтесь Авторизуйтесь
Ru En